Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Remote blended treatment for individuals with suicidal ideation: A single-arm proof-of-concept trial

Rebekka Büscher*, Tobias Teismann, Paula Hartleitner, Jan Philipp Klein, Harald Baumeister, Lasse B. Sander

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Introduction: New digital treatment formats may reduce barriers to treatment for individuals with suicidal ideation. This study aimed to investigate the feasibility of a remote blended care programme for this population, defined as acceptability, demand, practicality, adaptation, indications of efficacy and safety. Methods: We conducted a mixed-methods single-arm trial for proof-of-concept. Participants were eligible if they were at least 18 years old, had sufficient German proficiency, a Beck Scale for Suicidal Ideation score ≥2, internet access and lived near the outpatient clinic. The treatment consisted of 12 sessions of cognitive-behavioural videotherapy combined with online modules over 6 weeks. Results: We included 10 participants. All patients were satisfied with the treatment; most patients (80%) reported unpleasant memories resurfacing. All patients completed all therapy sessions and a mean of 13.7 modules (SD = 5.7); three patients switched to face-to-face treatment, in one case due to safety concerns. All patients and most therapists (83.3%) found the treatment overall practicable. Most patients (66.7%) and therapists (66.7%) considered remote treatment equivalent to face-to-face therapy. There were no serious adverse events. Conclusion: While promising, the results suggest changes to the programme might be needed, particularly for patients' safety. A controlled feasibility trial should investigate temporary deteriorations.

OriginalspracheEnglisch
Aufsatznummere2905
ZeitschriftClinical Psychology and Psychotherapy
Jahrgang31
Ausgabenummer1
ISSN1063-3995
DOIs
PublikationsstatusVeröffentlicht - 01.01.2024

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

DFG-Fachsystematik

  • 2.23-10 Klinische Psychiatrie, Psychotherapie und Kinder- und Jugendpsychiatrie

Fingerprint

Untersuchen Sie die Forschungsthemen von „Remote blended treatment for individuals with suicidal ideation: A single-arm proof-of-concept trial“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren